BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29396681)

  • 1. Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome.
    Coca-Pelaz A; Takes RP; Hutcheson K; Saba NF; Haigentz M; Bradford CR; de Bree R; Strojan P; Lund VJ; Mendenhall WM; Nixon IJ; Quer M; Rinaldo A; Ferlito A
    Adv Ther; 2018 Feb; 35(2):153-160. PubMed ID: 29396681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age, comorbidity, and WHO performance status on delay of treatment in patients undergoing fast-track work-up for head and neck cancer.
    Carlsen AH; Eriksen JG; Godballe C; Johansen J; Sørensen JA; Bjørndal K
    J Geriatr Oncol; 2019 Mar; 10(2):259-264. PubMed ID: 29950282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of delay and association with outcome in head and neck cancer: A systematic review.
    Schoonbeek RC; Zwertbroek J; Plaat BEC; Takes RP; Ridge JA; Strojan P; Ferlito A; van Dijk BAC; Halmos GB
    Eur J Surg Oncol; 2021 Aug; 47(8):1816-1827. PubMed ID: 33715909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma.
    DeGraaff LH; Platek AJ; Iovoli AJ; Wooten KE; Arshad H; Gupta V; McSpadden RP; Kuriakose MA; Hicks WL; Platek ME; Singh AK
    Oral Oncol; 2019 Sep; 96():148-152. PubMed ID: 31422206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck.
    Prabhash K; Babu G; Chaturvedi P; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Gairola M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; Rath GK
    Indian J Cancer; 2020 Feb; 57(Supplement):S1-S5. PubMed ID: 32167063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indian clinical practice consensus guidelines for the management of very advanced disease of squamous cell carcinoma of head and neck.
    Prabhash K; Babu G; Chaturvedi P; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Gairola M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; K RG
    Indian J Cancer; 2020 Feb; 57(Supplement):S22-S25. PubMed ID: 32167069
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival.
    van Harten MC; Hoebers FJ; Kross KW; van Werkhoven ED; van den Brekel MW; van Dijk BA
    Oral Oncol; 2015 Mar; 51(3):272-8. PubMed ID: 25541458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature.
    Bossi P; Alfieri S; Strojan P; Takes RP; López F; Mäkitie A; Saba NF; Rodrigo JP; Bradford C; Suarez C; Zafereo M; Forastiere AA; Vermorken JB; Quer M; Sanabria A; Simo R; de Bree R; Rinaldo A; Ferlito A
    Crit Rev Oncol Hematol; 2019 May; 137():84-91. PubMed ID: 31014517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
    González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
    J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.
    Polesel J; Lupato V; Collarile P; Vaccher E; Fanetti G; Giacomarra V; Palazzari E; Furlan C; Matrone F; Navarria F; Gobitti C; Minatel E; Serraino D; Birri S; Franchin G
    Med Oncol; 2019 Feb; 36(4):31. PubMed ID: 30815763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indian clinical practice consensus guidelines for the management of oropharyngeal cancer.
    Prabhash K; Babu G; Chaturvedi P; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Gairola M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; Rath GK
    Indian J Cancer; 2020 Feb; 57(Supplement):S12-S15. PubMed ID: 32167066
    [No Abstract]   [Full Text] [Related]  

  • 13. Indian clinical practice consensus guidelines for the management of oral cavity cancer.
    Chaturvedi P; Prabhash K; Babu G; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Gairola M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; Rath GK
    Indian J Cancer; 2020 Feb; 57(Supplement):S6-S8. PubMed ID: 32167064
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study.
    Schneider K; Marbaix E; Bouzin C; Hamoir M; Mahy P; Bol V; Grégoire V
    Acta Oncol; 2018 Sep; 57(9):1165-1172. PubMed ID: 29493423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving access and timeliness of care for veterans with head and neck squamous cell carcinoma: A multidisciplinary team's approach.
    Patil RD; Meinzen-Derr JK; Hendricks BL; Patil YJ
    Laryngoscope; 2016 Mar; 126(3):627-31. PubMed ID: 26267427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
    Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center.
    van Harten MC; de Ridder M; Hamming-Vrieze O; Smeele LE; Balm AJ; van den Brekel MW
    Oral Oncol; 2014 Apr; 50(4):282-90. PubMed ID: 24405882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinic.
    Light T; Rassi EE; Maggiore RJ; Holland J; Reed J; Suriano K; Stooksbury M; Tobin N; Gross N; Clayburgh D
    Head Neck; 2017 Jun; 39(6):1106-1112. PubMed ID: 28370667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
    Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
    Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
    Cho JK; Lee GJ; Kim HD; Moon UY; Kim MJ; Kim S; Baek KH; Jeong HS
    PLoS One; 2018; 13(9):e0203758. PubMed ID: 30192876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.